Categories
Health

Indonesia’s well being minister on delta Covid surge, hospital capability

Health Minister Budi Gunadi Sadikin said the Indonesian government increased hospital bed capacity in preparation for a surge in Covid infections after the holidays, but parts of the country are still running out of beds as daily cases hit new highs.

He told CNBC Street Signs Asia that Indonesia has up to 130,000 beds for Covid patients and 72,000 people have been in isolation beds as of yesterday.

But he admitted that the Southeast Asian nation faces two problems.

“The first problem is that the acceleration is much faster than it was in January and February,” he said. “So for a very dense area … we’re starting the mobility restrictions next week to ensure that the speed of incoming patients to the hospital is reduced.”

He attributed the increase in new cases to the Delta variant, which was first discovered in India.

Indonesia tightened restrictions on sources of infection last week and announced on Thursday that stricter emergency measures would apply from July 3 to July 20.

In the Jakarta region it already reaches 90% of the bed capacity.

Budi Gunadi Sadikin

Indonesia’s Minister of Health

The second problem is that the infections are concentrated in certain parts of the country, particularly the most populous island of Java.

“In the Jakarta region it already reaches 90% of the bed capacity,” he said on Wednesday.

Jan Gelfand of the International Federation of Red Cross and Red Crescent Societies said “action at lightning speed” is needed to give countries like Indonesia access to vaccines.

“Every day we see how this Delta variant brings Indonesia closer to the brink of a Covid-19 catastrophe,” said Gelfand, the head of the Indonesian delegation of the IFRC, in a press release.

No nationwide lockdown

The Indonesian health minister is reportedly pushing for stricter Covid measures in Indonesia, but told CNBC that authorities will not consider a nationwide lockdown.

“Definitely not, because … the cluster is only in a certain area,” he said. “Kalimantan doesn’t have that. Sulawesi doesn’t. Most of Sumatra doesn’t and (and) Bali is still under control.”

Indonesia’s tourism minister told Reuters this week that the country, Bali, a popular holiday destination, plans to reopen in late July or early August, but needs to “watch out for the recent surge” in cases.

Health Minister Budi said in Sumatra and Kalimantan only 30 to 40 percent of hospital beds were occupied. “It’s not evenly distributed.”

A Covid-19 patient in the complex of the Wisma Atlet Covid-19 Emergency Hospital.

Risa Krisadhi | SOPA pictures | LightRakete | Getty Images

He also said Indonesia could increase oxygen production if necessary, adding that the country has diverted some of its industrial supplies to hospitals.

Distribution is a problem, however, as the factories are mostly located in West and East Java, while Central Java needs oxygen, he said.

Vaccination progress

Regarding vaccinations, Budi said the country has given 43 million vaccinations to around 28 million people. This corresponds to a little more than 10% of the approximately 276 million inhabitants of Indonesia.

He said the vaccination rate has remained constant at around 1 million doses per day this week.

“Our president asked me to go from 1 million doses a day to 2 million doses a day, which … can be done because we are now asking the entire private sector, all the police and the entire army to help,” said he.

Indonesia has received donations from China, Japan, Australia, the United States and Covax, a global alliance that aims to provide vaccines to poorer countries, Budi said. It also had agreements to buy vaccines from AstraZeneca and Pfizer, he said.

According to the World Health Organization, the new Covid cases reported in Indonesia between June 21 and 27 are up 60% from the previous week. 2,476 deaths were also recorded during this period.

As of June 29, Indonesia has confirmed 2.16 million coronavirus infections and 58,024 deaths, data from Johns Hopkins University showed.

Categories
Health

Australia’s combined messages on Covid vaccines sow confusion

The introduction of vaccines in Australia has been slow and chaotic, with leaders and health advisers sending mixed messages.

The country’s top medical association recommends that people follow guidelines from the Australian Technical Advisory Group on Immunization when deciding which Covid vaccine to take. ATAGI advises the Minister of Health in Australia on vaccination issues.

“We recommend following expert advice, but at the end of the day people can make their own decisions as these are all safe and effective vaccines,” said Omar Khorshid, president of the Australian Medical Association, on CNBC’s “Squawk” on Thursday Box Asia. “

While Australia has been comparatively successful in controlling infection, it has faced some constraints on vaccine supplies. Currently, only the Pfizer BioNTech and Oxford AstraZeneca syringes are approved for use, and both require two doses for complete immunization.

Mixed news from the Australian government and ATAGI has created confusion – and hesitation – about the vaccines available and their safety.

What do experts say?

ATAGI says people between the ages of 16 and 59 should preferably get Pfizer shots, while the government says those people can choose AstraZeneca after consulting their doctors.

Pfizer shots are scarce in the country and reports say the majority of the cans might not arrive until the third quarter.

The recommendation of the advisory group came afterwards Data showed higher risks and observed severity of an extremely rare bleeding disorder – known as thrombosis and thrombocytopenia syndrome – associated with the use of AstraZeneca vaccines observed in Australian adults aged 50 and over.

June 2021, people are standing in front of a vaccination center in Sydney, as residents have largely been banned from leaving the city in order to stop a growing outbreak of the highly contagious Delta-Covid-19 variant in other regions.

SAEED KHAN | AFP | Getty Images

For those 60 years old and older, the group said the benefits of taking the AstraZeneca dose outweighed the risks of blood clots forming.

What is the government saying?

On Monday, Prime Minister Scott Morrison said people under the age of 60 can get the AstraZeneca vaccine if they wish, provided they have discussed it with their doctors. The country will introduce a new “no mistake compensation system” for general practitioners who administer Covid-19 vaccines, he added.

“The ATAGI Council speaks of a preference for AstraZeneca to be available and made available as preferred for people over 60. But the council is not ruling out the possibility of people under the age of 60 receiving the AstraZeneca vaccine, ”said Morrison, according to an official transcript from his press conference.

“So if you want to get the AstraZeneca vaccine we would encourage you to … go and have this conversation with your GP,” he said.

Vaccine progress

Khorshid of the Australian Medical Association said the vaccine rollout is progressing relatively well, despite the mixed messages and political tactics. He said about two-thirds of Australia’s most vulnerable population have already received at least one dose of the AstraZeneca vaccine and are expected to receive their second dose.

Still, statistics compiled by Our World in Data showed just over 23% of the population to have at least one dose of the vaccine, and only about 6% were fully vaccinated.

An aerial view of Sixty Martin Place, Sydney, Australia.

Mark Syke | View pictures | Universal picture group | Getty Images

Authorities are also making efforts to contain outbreaks in Australia as the country seeks to contain the spread of the highly contagious coronavirus delta variant, which was first discovered in India.

According to reports, seven cities with around 12 million people are now on lockdown, including Sydney, Brisbane and Perth.

Khorshid told CNBC that the medical association wants the national cabinet to be strengthened on broader issues such as agreements on border closings and hotel quarantine regulations.

Categories
Health

Why U.S. will not hit Fourth of July objectives

Biden’s government says it will miss its July 4th vaccination target

All that free beer, donuts, and baseball tickets won’t be enough to keep up with the pace of vaccinations.

President Joe Biden’s goal of getting at least one shot in the arms of 70% of US adults before the July 4th holidays is missed.

According to a CNBC analysis of CDC data, by then about 67% of adults will be at least partially vaccinated at the current vaccination rate.

Zoom In Icon Arrows pointing outwards

The president said he hoped Independence Day would mark a turning point in the pandemic.

Yet vaccination efforts have come up against a wall in some states, despite the fact that the Delta variant of the disease is rapidly spreading across the country.

More from Personal Finance:
States hope free joints and other perks will generate interest
More and more universities are demanding Covid vaccines
More people plan to quit when return to work plans take hold

From Krispy Kreme to cold money, there is now no shortage of incentives to entice Americans into the Covid vaccine. But vaccination rates stay below 70% and are likely to stay there, according to Iwan Barrankay, professor of business and public policy at Wharton.

“These incentives are a great idea and they are very engaging, but there is simply no evidence that these incentives address the barriers,” Barankay said.

“We get into a population of people who are vehemently against it or who have a life situation that is too complicated,” he said. This group will not be swayed by vaccine sweeteners like cash gifts, sports tickets and free food, he added.

For some, socio-economic barriers remain, such as childcare or time off work to get vaccinated.

Barrankay has spent years researching what works to encourage patients to take their medication. Financial incentives are not compelling for patients with complicated lives, he said. Low income, inadequate housing, lack of transportation, and caring for others in the household are all factors that can get in the way.

In some cases, there is no incentive that you can offer people.

Ivan Barankay

Wharton professor

For others, there are also behavioral barriers, including skepticism about the vaccine, that can be even more difficult to overcome.

“In some cases, there is no incentive you can give people,” Barankay said.

Some Americans, especially those in black, Hispanic, and rural communities, are more reluctant to get Covid vaccinations.

“People are influenced by others around them,” said Barrankay. “If you can change someone’s behavior in a community, it has a multiplier effect, but it is much more difficult work.”

Still, as vaccination rates plateau, public and private groups continue to increase the stakes – from million dollar payouts and even marijuana or a lap around a NASCAR track – to encourage more vaccinations.

In May, Maryland hosted the first of its $ 40,000 lottery draws for people who were vaccinated. Forty consecutive days of the drawing for a prize of $ 40,000 will end on July 4th with a final drawing for a payout of $ 400,000.

Ohio also hosts a series of cash prize draws with its own “Vax-a-Million” contest.

In the private sector, Krispy Kreme was one of the first in March to introduce a nationwide Covid vaccine incentive, offering a free glazed donut to every adult with a vaccination card. The company said it has already given away more than 1.5 million donuts. (The offer is still valid for the rest of the year.)

And Anheuser-Busch recently said it would buy “a round of beer” to anyone over the age of 21 once Biden’s 70% target is reached on July 4th.

A handful of states have reported that vaccination incentive programs have increased local vaccination rates in some populations following recent declines.

For its part, Ohio said its vaccination rates doubled in some counties after the state vaccine lottery was announced.

Recent data shows that the Gambit could be effective with certain groups and have few overall drawbacks, according to a Morning Consult report.

The survey of 2,200 adults, including nearly 1,600 unvaccinated people, found that men are more likely than women to say that these offers would get them to sign up for a vaccination.

Democrats, more than Republicans, also said they were more likely to get vaccinated if they could get free goods or services, and when broken down by generations, millennials were the most likely to say that certain freebies would encourage them to get vaccinated.

A separate survey by Blackhawk Network found that money is the most popular motivator over a sweepstakes, paid time off, free food or drink, or other commodity.

About 66% of unvaccinated adults said they would accept a monetary incentive, and 44% said they would even get vaccinated for $ 100 or less. Blackhawk Network surveyed more than 3,000 adults in June.

Subscribe to CNBC on YouTube.

Categories
Health

CureVac to ‘plow ahead’ with Covid vaccine regardless of trial outcomes     

An employee of the German biopharmaceutical company CureVac will demonstrate research on a vaccine against the coronavirus (COVID-19) disease in a laboratory in Tübingen on March 12, 2020.

Andreas Gebert | REUTERS

LONDON – CureVac plans to continue work on its Covid-19 vaccine despite disappointing results from clinical studies showing the vaccine is only 48% effective.

The German biotech company released its final analysis of the clinical trials of its coronavirus vaccine – known as CVnCoV – on Wednesday, confirming that the vaccine was 48% effective against Covid of all degrees of severity in all ages and 15 variants.

Pierre Kemula, CFO of CureVac, however, defended the vaccine on CNBC Thursday, saying the clinical trials were conducted at a time when several new strains of the virus were spreading around the world.

“We have to speak to the EMA now [European Medicines Agency] and want to make sure we have an open dialogue and share any data we have to assess the way forward, “he told CNBC’s Squawk Box Europe on Thursday.

When asked if it is worth developing the vaccine further when other successful vaccines are already in use in Europe and elsewhere, Kemula said the company had contractual obligations to meet.

“We have a contract with the European Commission to supply 225 million doses of the drug, so I think we need to move forward on that,” he said.

“There are a lot of vaccinations, there are a lot of people under 60 who haven’t had access to the vaccine before. So if we can contribute to the fight – in the short term in the pandemic, but also in the medium term with these other ways of [multivalents] … we are continuing to work on that. “Multivalent or polyvalent vaccines should immunize against more than one virus strain.

The results of the CureVac study, which enrolled 40,000 participants in ten countries in Latin America and Europe, showed that the vaccine was more effective in younger participants. The effectiveness rate among 18 to 60 year olds was 53% for diseases of any severity and increased to 77% for moderate and severe diseases in the same age group.

However, given that Covid-19 carries a higher risk for the elderly, the study results are disappointing, not least because two other vaccines made with messenger RNA (mRNA) – those from Pfizer-BioNTech and Moderna – have an efficacy greater than 90 % of have been shown to prevent Covid-19 infection. CureVac’s shares fell as much as 13% in Thursday’s pre-trading session.

Dr. Franz-Werner Haas, CEO of CureVac, defended the results in a statement on Wednesday, saying the vaccine “shows strong public health value” for those aged 18 to 60 and will be an “important contributor to tackling Covid.” -19 pandemic and the dynamic distribution of variants. “

He also cited “the current context of an increasingly diverse environment of Covid-19 variants”.

Several variants have emerged over the course of the pandemic, some of which are more virulent than others – like the alpha variant first discovered in the UK and the delta variant first identified in India – and Kemula said he believed mutations would continue to occur.

“As more and more people become infected with coronavirus, we are prepared for the disease to continue to develop as it progresses and has more and more variants,” said Kemula. The industry must think ahead, “how we can cope better with the current vaccines, but also possibly with various boosters (booster vaccinations),” he added.

Categories
Health

Dr. Barbara Murphy, Kidney Transplant Knowledgeable, Dies at 56

Dr. Barbara Murphy, a leading nephrologist who specialized in advanced research that focused on predicting and diagnosing the outcomes of kidney transplants, died on Wednesday at Mount Sinai Hospital in Manhattan, where she had worked since 1997. She was 56.

The cause was glioblastoma, an aggressive form of brain cancer, her husband, Peter Fogarty, said.

Dr. Murphy blended a passion for research into kidney transplant immunology with her role, since 2012, as the chairwoman of the department of medicine at the Icahn School of Medicine at Mount Sinai (and its broader health system). She was the first woman named to run a department of medicine at an academic medical center in New York City.

“In baseball, they talk about five-tool players,” Dr. Dennis S. Charney, dean of the Icahn School, said by phone. “I don’t know how many tools she had, but she was a very strong administrator, a great researcher and a great mentor to many people.”

Dr. Murphy, who was from Ireland, developed her interest in kidney transplantation while attending medical school at the Royal College of Surgeons in Dublin. She was drawn especially to how it transformed patients’ lives.

“I love seeing how well patients do afterward,” she told Irish America magazine in 2016. “For all the years that I’ve been in this profession, the interaction between a living donor and a recipient in the recovery room still makes me proud to be a physician and to play a part in such a life-affirming moment.”

After being recruited to Mount Sinai in 1997, she joined other researchers in examining the role of H.I.V. in kidney disease and helped establish the viability of kidney transplants for patients with H.I.V. In a speech at the Royal College in 2018, she recalled that there had been criticism of such transplants — as if there were a “moral hierarchy when it came to donor kidneys.”

She added, “Two weeks ago, we received an email from one of our patients, thanking us on his 15th renal transplant birthday.”

More recently, Dr. Murphy’s research at her laboratory at Mount Sinai focused on the genetics and genomics of predicting the results of transplants, and on why some kidneys are rejected.

In findings reported in The Lancet in 2016, she and her collaborators said they had identified a set of 13 genes that predicted which patients would subsequently develop fibrosis, a hallmark of chronic kidney disease, and, ultimately, irreversible damage to the transplanted organ. Being able to predict which patients were at risk, they wrote, would allow for treatment to prevent fibrosis.

Her research has been licensed to two companies. One, Verici DX, which is still in validation trials in advance of commercial sales, is developing RNA signature tests to determine how a patient is responding to, and will respond to, a transplant. The other company, Renalytix, uses an algorithm guided by artificial intelligence to identify a kidney disease risk score for patients. Dr. Murphy served on the boards of both companies.

“Barbara was foundational to Verici,” Sara Barrington, the company’s chief executive, said by phone. She added, “Her lab will continue to file new discoveries out of her base research.”

Barbara Therese Murphy was born on Oct. 15, 1964, in South Dublin. Her father, John, owned an airfreight company, and her mother, Anne (Duffy) Murphy, worked with him and also designed bridal wear.

At age 4, Dr. Murphy recalled in a speech at a health care awards dinner sponsored by Irish America in 2016, she had to overcome a harsh judgment by a teacher.

“My elementary school teacher told my mother I was a dunce and I would never be anything, and what’s more she shouldn’t even try,” she said. “Fortunately, my parents persevered.”

After earning her medical degree at the Royal College in 1989, Dr. Murphy completed her residency and a nephrology fellowship at Beaumont Hospital, also in Dublin. She was also a nephrology fellow in the renal division of Brigham and Women’s Hospital in Boston, where she trained in transplant immunology.

In 1997, she was recruited to Mount Sinai as director of transplant nephrology by Dr. Paul Klotman, then the chief of the division of nephrology, who promoted her to his former position in 2003 after he had become chairman of Icahn’s department of medicine.

“She showed a lot of promise in transplant nephrology, which was emerging at the time,” Dr. Klotman, now the president of the Baylor College of Medicine in Houston, said by phone. “Over the years, she developed good leadership skills: She was very organized and task oriented.”

In the spring of 2020, Dr. Murphy, like other physicians, noticed with alarm that Covid-19 was much more than a respiratory disease. It was causing a surge in kidney failure that led to shortages of machines, supplies and personnel needed for emergency dialysis.

The number of patients needing dialysis “is orders of magnitude greater than the number of patients we normally dialyze,” she told The New York Times.

One of Mount Sinai’s responses to the pandemic that May was to open the Center for Post-Covid Care for patients recovering from the virus. At the time, Mount Sinai had treated more than 8,000 patients who had been diagnosed with Covid-19.

“Barbara was instrumental in forming the center,” Dr. Charney said, “and she was involved in the follow-up as it related to kidney disease caused by Covid.”

Dr. Murphy was given the Young Investigator Award in Basic Science from the American Society of Transplantation in 2003 and was named nephrologist of the year by the American Kidney Fund in 2011. At her death, she was president-elect of the American Society of Nephrology.

In addition to her husband, Dr. Murphy is survived by their son, Gavin; her sister, Dr. Celine Murphy, a cardiologist who works in occupational health; her brother, Dr. Kieran Murphy, an interventional neuroradiologist; and her parents.

Dr. Murphy said she had learned an indelible lesson about the need for a strong patient-doctor relationship while still in medical school.

“Scholarship alone was not enough,” she said at the Irish America award ceremony. “An example: If we had a patient with rheumatoid arthritis and we shook their hands and they winced, it didn’t matter how much we knew about the disease or how to treat it, we’d failed our exam because we hadn’t taken the patient’s overall well-being into consideration.”

Categories
Health

New Covid wave has arrived in Europe, WHO says

Scotland fans arrive at King’s Cross Station on June 17, 2021 in London, England. Soccer games, taking place during the Euros, have been blamed for a rise in Covid cases numbers.

Rob Pinney | Getty Images Sport | Getty Images

A new wave of coronavirus cases could soon arrive in Europe, the World Health Organization warned Thursday, highlighting that a decline in the number of infections in the region has now come to an end.

“A 10-week decline in the number of Covid-19 cases in the 53 countries in the WHO European region has come to an end,” Hans Kluge, the WHO’s regional director for Europe, warned in a press briefing.

“Last week the number of cases rose by 10% driven by increased mixing, travel, gatherings and an easing of social restrictions,” he said.

The rise in cases comes against a backdrop of a “rapidly evolving situation,” Kluge said, given the new delta strain, which was dubbed a variant of concern by the WHO in May.

Millions remain unvaccinated in Europe, Kluge warned, with protection against the delta variant provided, for the most part, by having two doses of the Covid vaccines on offer. Kluge reiterated what the data has already shown, that the delta variant is far more transmissible than the alpha variant (which itself was more transmissible than previous strains).

Read more: The fast-spreading delta Covid variant could have different symptoms, experts say

“Delta overtakes alpha very quickly … and is already translating into increased hospitalizations and deaths,” Kluge said. He said the delta variant would be dominant in the WHO European region by August, while vaccinations would still not have caught up.

“By August, the WHO European Region will be ‘delta dominant,'” he noted, adding that 63% of people are still waiting for their first shot, while restrictions on public life are likely to be lifted by next month. The U.K., for example, which has a high vaccination rate but also a large number of cases caused by the delta variant, plans to end restrictions on July 19.

Read more: The Covid delta variant has ‘exploded’ in the UK — and it could be a blueprint for the U.S.

Kluge said that three conditions were now in place for “a new wave of excess hospitalizations and deaths” before the fall: new variants, a deficit in vaccine uptake and increased social mixing.

“There will be a new wave in the WHO European region unless we remain disciplined, and even more so when there is much less rules in place to follow,” he warned.

Medical staff member Mantra Nguyen installs a new oxygen mask for a patient in the Covid-19 intensive care unit (ICU) at the United Memorial Medical Center in Houston, Texas.

Go Nakamura | Getty Images News | Getty Images.

Rise in infections

Kluge’s comments come amid a worrying rise in Covid infections across Europe despite efforts to curtail travel from high-risk regions.

Others are now following the U.K., with France, Germany, Italy, Portugal and Russia among a group of countries seeing an increasing number of Covid cases being caused by the delta variant, particularly among younger, unvaccinated or not yet fully vaccinated people.

Read more: Europe wants to stop the Covid delta variant. But experts say it may already be too late

Increased mixing, particularly given the delayed UEFA Euro 2020 soccer tournament that’s currently being held across the Continent, has not helped prevent the spread of the variant with gatherings and crowds as matches are being played.

Categories
Health

How the U.S. Indian Well being Service works

Alaskan Indians and Native Americans are entitled to government-funded health care under contracts negotiated between tribal states and the US government.

“Our contracts state that we have a right to health care from the federal government,” said Abigail Echo-Hawk, a registered member of the Pawnee Nation of Oklahoma and executive vice president of the Seattle Indian Health Board. “This is supposed to be high quality health care provided to enrolled members of nationally recognized tribes free of charge because we have already paid for it with the land where the United States is located.”

However, according to a 2018 report by the independent and bipartisan Commission on Civil Rights, the US government has not adequately funded these programs, leaving many indigenous communities unable to provide quality care.

“Unless we get the resources we need, it will always be a struggle for us to address the underlying health conditions that have arisen as a result of colonial oppression and repression of both our health and our economic prosperity.” within the Indian country, “said Echo-Hawk.” Until we see full funding for the Indian health service, we will always struggle to do more than just meet the immediate needs of our people. “

In an email statement sent to CNBC, the Indian health service said it has received more than $ 9 billion in “historic investments” since the beginning of the Covid-19 pandemic, “to support long-standing health Addressing Alaskan and Native American inequalities to ensure a comprehensive public health response to the ongoing Covid-19 pandemic. “

Watch the video above to learn how federally funded health care for Alaskan Indians and Native Americans works, and why many activists and experts want the system to be reformed.

Categories
Health

Simply because the field workplace hit its stride, the delta variant appeared

A slow and steady increase in box office receipts could be threatened by a new variant of the coronavirus.

The domestic box office has gained momentum since March, bringing in up to $ 98.7 million in ticket sales last weekend, a record during the pandemic era.

Around 80% of the cinemas are open to the public this weekend, and mask restrictions on those who have received the coronavirus vaccination have been relaxed. With cinemas opening wider and Covid cases falling, studios have been confident of releasing big blockbuster pictures.

Last weekend, Universal’s “F9” hit the highest opening weekend of any movie released during the pandemic for a grand total of $ 70 million and helped increase total weekend loot to $ 98.7 million, another record for the industry .

Zoom In Icon Arrows pointing outwards

More than half of the US population has received at least one dose of the vaccine, which has resulted in a sharp decrease in the number of deaths from Covid, according to the Centers for Disease Control and Prevention. The number of new cases had fallen significantly in the last few weeks and is still well below its peak. However, public health officials are watching the spread of the highly contagious Delta variant in communities with low vaccination rates, which has led to a surge in cases recently.

It is feared that an increase in the cases of Delta variants could lead to a resurgence of health and safety restrictions not only domestically but also internationally and discourage worldwide moviegoers from going to the movies.

Cities like Los Angeles have already chosen to reverse mask guidelines and strongly recommend that both unvaccinated and vaccinated individuals wear masks in public places such as restaurants, shops, and movie theaters. Cinema chains have told CNBC that cinema locations will continue to comply with all local regulations.

“Each state is loosening mask strategies so many companies could be affected if it flares up,” said Eric Handler, media and entertainment analyst at MKM Partners. “I hope the vaccines can help fight it off enough that it’s not a big problem.”

CDC director Rochelle Walensky said Wednesday that the US has a high vaccination rate and its highly potent vaccines have allowed them to relax mask restrictions and social distancing measures. In comparison, much of the world is still unvaccinated and there is currently evidence that vaccines developed outside of the United States have been less effective.

“The global outlook also remains important as studios and exhibitors closely monitor key international markets and the evolution of their various vaccine distributions in the second half of the year,” said Shawn Robbins, chief analyst at Boxoffice.com.

In some countries where the Delta variant is on the rise, new lockdown measures have been imposed.

The Delta variant currently accounts for about 25% of the new cases sequenced in the US, and officials believe it will become the dominant strain in the country. In some counties, the delta variant rates are up to 50% according to the CDC.

The US government is concerned about parts of the US where vaccination rates are low. Domestically, about 1,000 counties in the United States have a vaccination coverage rate of less than 30%, Walensky said Thursday. These counties are mainly in the Southeast and Midwest and are the most prone to getting Covid infection, she said. The authority already sees increasing disease rates in these districts due to the further spread of the more transmissible delta variant.

“The movie industry, like many others, has been considering variant scenarios similar to the current one under the reopening plans and nothing is taken for granted,” said Robbins. “At this point, however, there is no evidence of an immediate impact on domestic cinemas as long as the vaccinated individuals remain protected, as health officials have widely reported.”

– CNBC’s Rich Mendez contributed to this report.

Disclosure: Comcast is the parent company of NBCUniversal and CNBC. NBCUniversal is the distributor of “F9”.

Categories
Health

Air Air pollution’s Invisible Toll on Your Well being

President Biden’s proposed infrastructure plan calling for huge investments in clean energy, public transportation and electric vehicles would do a lot more than slow the rate of devastating climate change. It would also protect the health of every American, especially young children and older adults, by reducing the harmful effects of the invisible air pollutants inhaled year after year.

Toxic substances like fine particulate matter, nitrogen dioxide and ozone form primarily when fossil fuels are burned and enter the atmosphere in the exhaust from motor vehicles, heating units and smoke from wildfires. Inhaling such pollutants can cause bodily damage that lasts for years, if not for life, and may even lead to death.

Air pollution has long been recognized as a human health hazard, prompting the enactment of the Clean Air Act of 1963. Under the act, air quality standards are periodically revised by the Environmental Protection Agency. Though these standards are meant to be based on up-to-date research, they are subject to economic and political pressures, sometimes at the expense of public health.

Those most vulnerable to illness and premature death related to air pollution include children, pregnant women, the elderly and those with pre-existing heart or lung disease. The risk is greatest among people who live in poor neighborhoods, many of which are close to major roads or near industrial sources of pollution.

Since 1990, implementation of the amended Clean Air Act has resulted in about a 50 percent decline in emissions of key air pollutants. Still, new research has shown that this decline is not nearly enough to protect the most vulnerable Americans from the damaging effects of air pollution. A 17-year study based on hospital records of more than 63 million older adults has shown that as recently as 2016, as a group they faced serious health risks from breathing levels of pollutants even at pollution levels that are below current national and international guidelines. For example, for each unit increase in long-term exposure to fine particulates in the air (measuring 2.5 micrometers in diameter and invisible to the naked eye), 2,536 people were hospitalized with strokes.

The report, published in the journal Circulation, found that years of breathing low concentrations of fine particulate matter, nitrogen dioxide and ozone “poses a significant risk to cardiovascular and respiratory health among the elderly population of the United States.” Translation: Older people are more likely to suffer a heart attack, stroke, atrial fibrillation and pneumonia because of air pollution, resulting in thousands of additional hospital admissions each year.

A team of 12 scientists, headed by Mahdieh Danesh Yazdi of the Harvard School of Public Health, based this finding on an analysis of air pollution exposure and health outcomes among all fee-for-service Medicare beneficiaries aged 65 and older who were living in the United States between 2000 and 2016.

“Each unit increase in levels of particulate matter, nitrogen dioxide and ozone were associated with thousands of additional admissions” to hospitals each year, the team reported. Dr. Yazdi, a professor and research fellow in environmental health, said in an interview that “hundreds of thousands of lives could be saved” by improving the quality of the air that Americans breathe.

With half the population of the United States routinely exposed to levels of common pollutants shown to be hazardous in the study, the researchers concluded that “this issue should be of great concern to clinicians and policymakers alike.”

By making the data on air quality and health outcomes publicly available, Dr. Yazdi said, the team hoped to give people “some power” to improve air quality and better protect public health.

“Both clinicians and patients can be advocates and apply pressure on public officials to control the sources of pollution and improve the air we all breathe,” she said. “Even if air pollution can’t be fully mitigated, we should strive to do better. Levels of pollutants now considered safe can still have harmful effects and result in bad outcomes.”

The team also suggested that people pay attention to the air quality where they live and do their best “to avoid harmful exposure over long periods of time.” There was a dramatic example of such avoidance last summer when wildfires burned across the state of California, forcing many people to remain indoors with windows and doors shut to minimize breathing smoke-related pollutants.

According to the Environmental Protection Agency, “Larger and more intense wildfires are creating the potential for greater smoke production and chronic exposures in the United States, particularly in the West.”

But while such extreme short-lived instances of severe air pollution are readily identified, so-called background levels remain unnoticed and unmonitored by the general public, leaving millions of people susceptible to the insidious damage they can cause. You can get a reasonable estimate of these levels by checking the Air Quality Index where you live each day, and avoiding prolonged or heavy exertion outdoors on days when air quality is poor.

Worldwide, an international research team reported last year, air pollution “accounts for about 9 million deaths per year,” they wrote in Frontiers in Public Health. “The health of susceptible and sensitive individuals can be impacted even on low pollution days.”

Particulate matter contains tiny liquid or solid droplets that are easily inhaled. In addition to damaging the lungs, these microscopic particles can enter the bloodstream and have damaging effects elsewhere in the body, including the brain.

People over 75 in the new study were more likely to be hospitalized than those closer to 65, and whites faced a greater risk of admission than Black individuals from exposure to particulate matter. But exposure to nitrogen dioxide, also a product of burning fossil fuels, was shown to be more harmful to Blacks than to whites.

Furthermore, for the study population overall, the greatest risk of hospital admissions occurred at lower concentrations of air pollutants, the team reported.

Other studies have shown that even short-term exposure to low levels of pollutants can be hazardous to people with conditions like chronic obstructive pulmonary disease (COPD) and asthma. Exposure to air pollution early in life can result in respiratory, cardiovascular, mental and perinatal disorders, according to the United States Global Change Research Program.

Air pollution can also have indirect health effects because of its close link to climate change. Pollutants increase the amount of sunlight that reaches the earth, warming it, and warmer climates increase the spread and intensity of infectious diseases that can result in epidemics

Given that most of pollutants we inhale enter the atmosphere from sources like industrial machinery, power plants, combustion engines and cars, efforts to switch from fossil fuels to clean energy sources like wind power and powering vehicles with electric energy instead of gasoline and diesel can have a major impact on air quality.

Categories
Health

White Home to deploy response groups throughout U.S. to fight Covid variant

The White House is deploying Covid-19 response teams across the United States focused on combatting the highly contagious delta variant, the Biden administration announced Thursday.

The teams, comprised of officials from the Centers for Disease Control and Prevention and other federal agencies, will work with communities at higher risk of experiencing outbreaks and will focus on increasing the rate of Covid-19 vaccinations, White House Covid czar Jeff Zients said during a White House news briefing on the pandemic.

The teams will also increase testing to expand detection of the virus, facilitate contact tracing and provide therapeutics to help treat those who become infected, he said, adding the government is ready to provide additional personnel.

There are 1,000 counties in the U.S. that have vaccination coverage of less than 30%, CDC Director Dr. Rochelle Walensky said at the briefing. These counties, primarily in the South and Midwest, are the most vulnerable to the variant, she said.

“To be clear, the federal government stands ready to meet the moment and work with our state partners to respond to the delta variant,” Zients said.

“As we continue to work with communities across the country to get more shots in arms, we will also be working with governors and state and local health authorities to identify and address the needs on the ground in places with emergency outbreaks,” he added.

The Biden administration’s comments come just ahead of the Fourth of July weekend, when many Americans are expected to gather for fireworks, barbeques and other large, in-person activities.

Delta, first identified in India but now in at least 96 countries, is expected to become the dominant variant of the disease in the U.S. The prevalence of the delta, estimated to be about 60% more transmissible than the alpha variant first found in the U.K., is doubling in the U.S. about every two weeks, according to the CDC.

Health officials say there were reports that the delta variant also causes more severe symptoms, but that more research is needed to confirm those conclusions. Still, there are signs the delta strain could provoke different symptoms than other variants.

This is a “highly contagious virus,” said Dr. Paul Offit, a pediatrician and vaccine advocate who has served on advisory panels for both the CDC and the Food and Drug Administration.

“We need to vaccinate now. I mean get everyone vaccinated now because these mutations are going to continue to occur,” he said. It’s only July but “as we head into the fall and early winter you’re going to see a surge and there are too many people in this country who are still unvaccinated.”

Delta accounts for around 26% of Covid cases in the U.S., the CDC has estimated. Dr. Anthony Fauci, the White House’s chief medical advisor, has called the variant the “greatest threat” to the nation’s attempt to eliminate Covid-19.

The WHO has said the variant is the fastest and fittest coronavirus strain yet, and it will “pick off” the most vulnerable people, especially in places with low Covid vaccination rates. It recently urged everyone, including vaccinated people, to continue to wear masks as the variant spreads.

In some regions of the country, nearly one in two sequences is the delta variant, Walensky said Thursday. As the variant spreads, officials expect to see an increase in transmission unless states can vaccinate more people, she added.

As of Thursday, more than 181 million Americans, or 54.6% of the U.S. population, have had at least one dose of a Covid vaccine, according to data compiled by the CDC. More than 155 million Americans are fully vaccinated, according to the CDC.

“The delta variant is predicted to be the second most prevalent variant in the United States, and I expect that in the coming weeks it will eclipse the alpha variant,” she said, urging those with symptoms to get tested for Covid.